The Hormones in Bulk Except Contraceptives and Antibiotics market in South Africa experienced minimal fluctuation from 2013 to 2023, with the value per capita hovering between $0.12 and $0.14. A slight increase was observed in 2020 and 2021, moving to $0.14, but returned to $0.13 in 2022 and 2023. The year-on-year variation for the last two years indicates a stable market with a negligible negative growth of 0% from 2022 to 2023. The compounded annual growth rate (CAGR) over the last five years suggests a steady, flat trend, reflecting maturity in this segment.
Future trends to watch include potential innovations in hormone production technology, changes in healthcare policies affecting bulk hormone usage, and shifts in consumer demand driven by health and wellness trends. Monitoring these factors will be crucial for predicting market movements post-2023.
